X-linked inhibitor of apoptosis protein regulates human interleukin-6 in umbilical vein endothelial cells via stimulation of the nuclear factor-kappaB and MAP kinase signaling pathways.

Journal Title: Pharmacological Reports - Year 2006, Vol 58, Issue 0

Abstract

X-linked inhibitior of apoptosis (XIAP) is known as a potent inhibitor of apoptosis, but more recently has been shown to also act as a modulator of the nuclear factor kB (NF-kappaB) signaling pathway. To investigate whether XIAP also affects other signalling pathways, we studied the transcriptional regulation of interleukin 6 (IL-6), a gene that is strongly affected by XIAP, in more detail. The human IL-6 gene contains transcription factor binding sites for activator protein 1 (AP1), enhancer binding protein beta (C/EBP-beta) and NF-kappaB. In reporter gene assays, mutation of these binding sites revealed the necessity of functional NF-kappaB and AP1-sites for its ability to respond to XIAP. In contrast, IL-6 promoter activity was slightly increased in the C/EBP deletion mutant. Pharmacologic inhibition of extracellular signal regulated kinase (ERK) kinases (MEK1/2) as well as inhibition of the p38 signaling pathway both reduced XIAP-induced IL-6 promoter activity. In conclusion, these results suggest that XIAPregulates IL-6 transcription via NF-kappaB in cooperation with AP1 and C/EBP-beta.

Authors and Affiliations

Ulrike Resch, Gabriele Winsauer, Renate Hofer-Warbinek, Rainer de Martin

Keywords

Related Articles

Abnormalities of the resistance vasculature in hypertension: correction by vasodilator therapy.

The structure of the resistance vessels in patients with essential hypertension is altered, with reduction of the lumen diameter and increase in wall-to-lumen ratio without change inwall mass, known as eutrophic remodell...

Dose-response relationship analysis of pregabalin doses and their antinociceptive effects in hot-plate test in mice.

The aim of this study was to determine the analgesic effects of pregabalin (a third-generation antiepileptic drug) using the acute thermal pain model (hot-plate test) in mice. Linear regression analysis was used to evalu...

Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells.

Background: Dihydroartemisinin (DHA) exhibits potent anti-malarial and anti-cancer activities. This study aimed to investigate the anti-proliferative effects of a combination of DHA and doxorubicin (DOX) on human breast...

Effects of acetylsalicylic acid on the levels of sulfane sulfur and non-protein sulfhydryl groups in mouse tissues.

Background: The study is focused on searching for the link between acetylsalicylic acid (ASA) and sulfur metabolism. The present work aimed to investigate the effect of ASA on the level of the sulfane sulfur and non-prot...

Antidepressant-like effects of baclofen and LY367385 in the forced swim test in rats.

Baclofen, an agonist of GABA(B) receptors and LY367385, an antagonist of mGluR(1a) receptors, given alone or jointly, reduced the immobility time in the forced swim test but only their separate administration enhanced mo...

Download PDF file
  • EP ID EP154671
  • DOI -
  • Views 71
  • Downloads 0

How To Cite

Ulrike Resch, Gabriele Winsauer, Renate Hofer-Warbinek, Rainer de Martin (2006). X-linked inhibitor of apoptosis protein regulates human interleukin-6 in umbilical vein endothelial cells via stimulation of the nuclear factor-kappaB and MAP kinase signaling pathways.. Pharmacological Reports, 58(0), 111-117. https://europub.co.uk/articles/-A-154671